Bhatnagar Anish, CHIEF EXECUTIVE OFFICER at SOLENO THERAPEUTICS INC (SLNO), sold 254,688 shares at $45.89 ($11.6M) on 2024-08-06, disclosed to the SEC on 2024-08-07.
Open-market sale of $11.6M SLNO by CHIEF EXECUTIVE OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.48 | 32,789 | $1.5M | 12.8% |
| 2 | $45.48 | 32,789 | $1.5M | 12.8% |
| 3 | $46.14 | 25,424 | $1.2M | 10.1% |
| 4 | $46.14 | 25,424 | $1.2M | 10.1% |
| 5 | $43.64 | 6,789 | $296K | 2.6% |
| 6 | $43.64 | 6,789 |
| $296K |
| 2.6% |
| 7 | $45.25 | 22,937 | $1.0M | 8.9% |
| 8 | $45.25 | 22,937 | $1.0M | 8.9% |
| 9 | $45.89 | 39,405 | $1.8M | 15.6% |
| 10 | $45.89 | 39,405 | $1.8M | 15.6% |
| Total | $45.60 avg | 254,688 | $11.6M | 100% |
| Filing → |
| SLNO | SELL | 2024-10-03 | $2.0M | — | Filing → |
| SLNO | SELL | 2024-08-30 | $10.9M | — | Filing → |
| SLNO | SELL | 2024-07-03 | $1.6M | — | Filing → |